BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 35682726)

  • 1. Molecular Basis of Bile Acid-FXR-FGF15/19 Signaling Axis.
    Katafuchi T; Makishima M
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in the Digestive, Metabolic and Therapeutic Effects of Farnesoid X Receptor and Fibroblast Growth Factor 19: From Cholesterol to Bile Acid Signaling.
    Di Ciaula A; Bonfrate L; Baj J; Khalil M; Garruti G; Stellaard F; Wang HH; Wang DQ; Portincasa P
    Nutrients; 2022 Nov; 14(23):. PubMed ID: 36500979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile Acids as Hormones: The FXR-FGF15/19 Pathway.
    Kliewer SA; Mangelsdorf DJ
    Dig Dis; 2015; 33(3):327-31. PubMed ID: 26045265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation.
    Rau M; Stieger B; Monte MJ; Schmitt J; Jahn D; Frey-Wagner I; Raselli T; Marin JJ; Müllhaupt B; Rogler G; Geier A
    Inflamm Bowel Dis; 2016 Oct; 22(10):2382-9. PubMed ID: 27580383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic cholesterol accumulation ascribed to the activation of ileum Fxr-Fgf15 pathway inhibiting hepatic Cyp7a1 in high-fat diet-induced obesity rats.
    Duan Y; Zhang F; Yuan W; Wei Y; Wei M; Zhou Y; Yang Y; Chang Y; Wu X
    Life Sci; 2019 Sep; 232():116638. PubMed ID: 31288013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of β-Klotho.
    Fu T; Kim YC; Byun S; Kim DH; Seok S; Suino-Powell K; Xu HE; Kemper B; Kemper JK
    Mol Endocrinol; 2016 Jan; 30(1):92-103. PubMed ID: 26505219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis.
    Byun S; Jung H; Chen J; Kim YC; Kim DH; Kong B; Guo G; Kemper B; Kemper JK
    J Biol Chem; 2019 May; 294(22):8732-8744. PubMed ID: 30996006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acids: regulation of synthesis.
    Chiang JY
    J Lipid Res; 2009 Oct; 50(10):1955-66. PubMed ID: 19346330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactoferrin promotes bile acid metabolism and reduces hepatic cholesterol deposition by inhibiting the farnesoid X receptor (FXR)-mediated enterohepatic axis.
    Ling CJ; Xu JY; Li YH; Tong X; Yang HH; Yang J; Yuan LX; Qin LQ
    Food Funct; 2019 Nov; 10(11):7299-7307. PubMed ID: 31626262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis.
    Modica S; Petruzzelli M; Bellafante E; Murzilli S; Salvatore L; Celli N; Di Tullio G; Palasciano G; Moustafa T; Halilbasic E; Trauner M; Moschetta A
    Gastroenterology; 2012 Feb; 142(2):355-65.e1-4. PubMed ID: 22057115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective FXR-FGF15 signaling and bile acid homeostasis in cystic fibrosis mice can be restored by the laxative polyethylene glycol.
    Bertolini A; van de Peppel IP; Doktorova-Demmin M; Bodewes FAJA; de Jonge H; Bijvelds M; Verkade HJ; Jonker JW
    Am J Physiol Gastrointest Liver Physiol; 2019 Mar; 316(3):G404-G411. PubMed ID: 30653340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small Heterodimer Partner and Fibroblast Growth Factor 19 Inhibit Expression of NPC1L1 in Mouse Intestine and Cholesterol Absorption.
    Kim YC; Byun S; Seok S; Guo G; Xu HE; Kemper B; Kemper JK
    Gastroenterology; 2019 Mar; 156(4):1052-1065. PubMed ID: 30521806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FXR an emerging therapeutic target for the treatment of atherosclerosis.
    Mencarelli A; Fiorucci S
    J Cell Mol Med; 2010 Jan; 14(1-2):79-92. PubMed ID: 20041971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice.
    Stroeve JH; Brufau G; Stellaard F; Gonzalez FJ; Staels B; Kuipers F
    Lab Invest; 2010 Oct; 90(10):1457-67. PubMed ID: 20531290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile acid signal-induced phosphorylation of small heterodimer partner by protein kinase Cζ is critical for epigenomic regulation of liver metabolic genes.
    Seok S; Kanamaluru D; Xiao Z; Ryerson D; Choi SE; Suino-Powell K; Xu HE; Veenstra TD; Kemper JK
    J Biol Chem; 2013 Aug; 288(32):23252-63. PubMed ID: 23824184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH.
    Hernandez GV; Smith VA; Melnyk M; Burd MA; Sprayberry KA; Edwards MS; Peterson DG; Bennet DC; Fanter RK; Columbus DA; Steibel JP; Glanz H; Immoos C; Rice MS; Santiago-Rodriguez TM; Blank J; VanderKelen JJ; Kitts CL; Piccolo BD; La Frano MR; Burrin DG; Maj M; Manjarin R
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G582-G609. PubMed ID: 32003601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15.
    Zhou M; Luo J; Chen M; Yang H; Learned RM; DePaoli AM; Tian H; Ling L
    J Hepatol; 2017 Jun; 66(6):1182-1192. PubMed ID: 28189755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influences of cholecystectomy on the circadian rhythms of bile acids as well as the enterohepatic transporters and enzymes systems in mice.
    Zhang F; Duan Y; Xi L; Wei M; Shi A; Zhou Y; Wei Y; Wu X
    Chronobiol Int; 2018 May; 35(5):673-690. PubMed ID: 29381405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor 15, induced by elevated bile acids, mediates the improvement of hepatic glucose metabolism after sleeve gastrectomy.
    Wei M; Cao WB; Zhao RD; Sun DP; Liang YZ; Huang YD; Cheng ZW; Ouyang J; Yang WS; Yu WB
    World J Gastroenterol; 2023 Jun; 29(21):3280-3291. PubMed ID: 37377582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.
    Schmitt J; Kong B; Stieger B; Tschopp O; Schultze SM; Rau M; Weber A; Müllhaupt B; Guo GL; Geier A
    Liver Int; 2015 Apr; 35(4):1133-1144. PubMed ID: 25156247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.